CoreTissue BioEngineering is a medical care provider through development of artificial ligament and other medical devices.
CoreTissue BioEngineering has raised $3.9M in total funding. The most recent round was Series A. The last funding was announced in November 2025.
CoreTissue BioEngineering's investors include WERU Investment, Mitsui Sumitomo Insurance Company, WASEDA University Ventures, Teijin, Next G Investment.
CoreTissue BioEngineering is headquartered in Tsurumi, Japan.
CoreTissue BioEngineering is a medical care provider through development of artificial ligament and other medical devices.
CoreTissue BioEngineering is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CoreTissue BioEngineering — Funding & Investors." VCBacked, November 10, 2025, https://www.vcbacked.co/company/coretissue-bioengineering. Accessed August 14, 2026.
VCBacked. (2025). CoreTissue BioEngineering — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/coretissue-bioengineering
{{cite web |title=CoreTissue BioEngineering — Funding & Investors |url=https://www.vcbacked.co/company/coretissue-bioengineering |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated